Strategic Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Strategic Advisors’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-7,958	Closed	-$491K	–	132
2016 Q3	$491K	Sell	7,958 -1,562	-16%	-$102K	0.28%	91
2016 Q2	$603K	Sell	9,520 -525	-5%	-$33K	0.35%	80
2016 Q1	$604K	Sell	10,045 -9,935	-50%	-$608K	0.34%	85
2015 Q4	$1.4M	Sell	19,980 -589	-3%	-$41.8K	0.91%	37
2015 Q3	$1.36M	Sell	20,569 -65	-0.3%	-$5.06K	0.95%	34
2015 Q2	$1.62M	Buy	20,634 +11,830	+134%	+$921K	1.03%	29
2015 Q1	$538K	Sell	8,804 -6,423	-42%	-$472K	0.34%	90
2014 Q4	$1.01M	Buy	15,227 +2,458	+19%	+$164K	0.66%	51
2014 Q3	$813K	Buy	12,769 +3,965	+45%	+$245K	0.53%	66
2014 Q2	$538K	Buy	8,804 +5,254	+148%	+$305K	0.34%	90
2014 Q1	$201K	Buy	+3,550	New	+$202K	0.13%	131

Other funds holding PJP

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Strategic Advisors's PJP Position: Q4 2016 in Review

Strategic Advisors sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2016, closing a stake of 7,958 shares — an estimated $491K sold.

Strategic Advisors first reported a position in PJP in Q1 2014 and held it in 11 quarters. The position peaked at $1.62M in Q2 2015. 101 funds tracked by Wall St. Rank hold PJP as of Q4 2016.

Strategic Advisors reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2016 after selling out during the quarter.
Strategic Advisors sold 7,958 Invesco Pharmaceuticals ETF shares in Q4 2016, an estimated $491K.
Strategic Advisors first reported a position in Invesco Pharmaceuticals ETF in Q1 2014 and held it in 11 quarters.
Strategic Advisors's Invesco Pharmaceuticals ETF position peaked at $1.62M in Q2 2015.
101 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2016.

Based on Strategic Advisors's 13F filing for Q4 2016, filed 6 Feb 2017.